MEDICINOVA, INC. Debt Related Commitment Fees and Debt Issuance Costs
MEDICINOVA, INC. (MNOV) reported Debt Related Commitment Fees and Debt Issuance Costs of -$1.04 thousand for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts · last filed 2011-11-14
- MEDICINOVA, INC. debt related commitment fees and debt issuance costs for the quarter ending 2011-09-30 was -$1.04K.
- MEDICINOVA, INC. debt related commitment fees and debt issuance costs for the quarter ending 2010-09-30 was $0.00.
| Period end | Debt Related Commitment Fees and Debt Issuance Costs 3 month | Debt Related Commitment Fees and Debt Issuance Costs 9 month | Debt Related Commitment Fees and Debt Issuance Costs 132 month |
|---|---|---|---|
| 2011-09-30 | -$1.04K 10-Q · filed 2011-11-14 | $492.71K 10-Q · filed 2011-11-14 | $492.71K 10-Q · filed 2011-11-14 |
| 2010-09-30 | $0.00 10-Q · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |